Wyeth Says Fracture Data Review Will Delay Viviant Launch
FDA is expected to issue an “approvable” letter April 23 for the osteoporosis therapy requesting three-year fracture data, pushing action date to year-end.
FDA is expected to issue an “approvable” letter April 23 for the osteoporosis therapy requesting three-year fracture data, pushing action date to year-end.